EP1974721A1 — Injectable sterile pharmaceutical composition with piperacillin sodium and tazobactam sodium as active principles
Assigned to ACS Dobfar SpA · Expires 2008-10-01 · 18y expired
What this patent protects
A sterile pharmaceutical composition having as its active principles piperacillin sodium and tazobactam sodium of substantially the same density, mixed with sodium bicarbonate: the mixture is soluble in water to give injectable reconstituted solutions having high stability with t…
USPTO Abstract
A sterile pharmaceutical composition having as its active principles piperacillin sodium and tazobactam sodium of substantially the same density, mixed with sodium bicarbonate: the mixture is soluble in water to give injectable reconstituted solutions having high stability with time.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.